A carregar...
Utilization of bevacizumab in US elderly patients with colorectal cancer receiving chemotherapy
OBJECTIVE: Bevacizumab, the first FDA-approved anti-angiogenesis agent, has been used for metastatic colorectal cancer since 2004. This study evaluated the utilization of bevacizumab among elderly metastatic colorectal cancer patients in the United States. METHODS: Using Surveillance and Epidemiolog...
Na minha lista:
| Publicado no: | J Oncol Pharm Pract |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883010/ https://ncbi.nlm.nih.gov/pubmed/24122849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155213507010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|